Stephen R. Brady, EVP, Strategy & Finance at Immune Design Corp. (IMDZ), sold 3,328 shares at $4.17 ($14K) on 2018-01-05, disclosed to the SEC on 2018-01-08.
Scheduled sale ($14k) by EVP, Strategy & Finance under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| Filing → |
| IMDZ | SELL | 2017-01-06 | $9K | — | Filing → |
| IMDZ | BUY | 2016-07-19 | $10K | — | Filing → |